You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Waldenström macroglobulinaemia

Showing 1 - 25 of 76
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Waldenstrom Macroglobulinemia, Waldenstrom's Disease, Waldenström; Hypergammaglobulinemia Trial in New York (Ibrutinib,

Recruiting
  • Waldenstrom Macroglobulinemia
  • +6 more
  • New York, New York
    Weill Cornell Medicine
Dec 21, 2021

Waldenstrom's Macroglobulinaemia Trial in United Kingdom (Bortezomib, Cyclophosphamide, Rituximab)

Completed
  • Waldenstrom's Macroglobulinaemia
  • Basingstoke, United Kingdom
  • +29 more
Jun 17, 2021

Waldenstrom Macroglobulinemia Trial in United Kingdom (Pembrolizumab, Rituximab)

Recruiting
  • Waldenstrom Macroglobulinemia
  • Plymouth, Devon, United Kingdom
  • +7 more
May 17, 2021

Waldenstrom Macroglobulinemia Trial in United Kingdom (Dexamethasone, cyclophosphamide, rituximab, Rituximab, ibrutinib)

Recruiting
  • Waldenstrom Macroglobulinemia
  • Dexamethasone, cyclophosphamide, rituximab
  • Rituximab, ibrutinib
  • Bournemouth, United Kingdom
  • +6 more
Dec 16, 2020

Waldenstrom Macroglobulinemia Trial in Tianjin (Zanubrutinib, Bendamustine and Rituximab)

Recruiting
  • Waldenstrom Macroglobulinemia
  • Zanubrutinib, Bendamustine and Rituximab
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Jun 13, 2023

Waldenström's Macroglobulinemia Trial in Busan (Lenalidomide, Bortezomib, Rituximab, Dexamethasone)

Recruiting
  • Waldenström's Macroglobulinemia
  • Lenalidomide, Bortezomib, Rituximab, Dexamethasone
  • Busan, Sue-gu, Korea, Republic of
    Kosin University Gospel Hospital
Mar 31, 2022

Solid Tumor Trial in Singapore (CURATE.AI, Capecitabine, XELOX)

Recruiting
  • Solid Tumor
  • CURATE.AI
  • +4 more
  • Singapore, Singapore
  • +1 more
Dec 14, 2021

Waldenström's Macroglobulinemia (WM) Trial in China (Zanubrutinib)

Completed
Has Results
  • Waldenström's Macroglobulinemia (WM)
  • Beijing, Beijing, China
  • +10 more
Mar 7, 2022

Chronic Lymphocytic Leukemia (CLL), Waldenstrom Macroglobulinemia (WM) Trial in Rochester (Shingrix vaccine)

Completed
  • Chronic Lymphocytic Leukemia (CLL)
  • Waldenstrom Macroglobulinemia (WM)
  • Shingrix vaccine
  • Rochester, New York
    University of Rochester
Jan 9, 2023

Transformed Waldenström Macroglobulineamia

Completed
  • Transformed Waldenström Macroglobulineamia
  • Non Applicable
  • Reims, France
    Chu Reims
Jul 27, 2018

Waldenstrom Macroglobulinemia, B-Cell Lymphoproliferative Disorder Trial in Boston (Pirtobrutinib, Venetoclax, Allopurinol)

Not yet recruiting
  • Waldenstrom Macroglobulinemia
  • B-Cell Lymphoproliferative Disorder
  • Boston, Massachusetts
  • +2 more
Feb 18, 2023

B-cell Lymphoma, Chronic Lymphocytic Leukaemia, Waldenström Macroglobulinemia Trial in United Kingdom (BI-1206 single agent dose

Completed
Has Results
  • B-cell Lymphoma
  • +2 more
  • BI-1206 single agent dose escalation phase
  • +3 more
  • Leicester, England, United Kingdom
  • +4 more
Jun 17, 2021

Waldenstrom Macroglobulinemia Trial (Zanubrutinib)

Not yet recruiting
  • Waldenstrom Macroglobulinemia
  • (no location specified)
Nov 28, 2022

IgM MGUS, Waldenstrom Macroglobulinemia, Neuropathy;Peripheral Trial in Boston (Acalabrutinib, Rituximab)

Recruiting
  • IgM MGUS
  • +2 more
  • Boston, Massachusetts
  • +1 more
Nov 14, 2022

Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma Trial in United States (Zilovertamab vedotin)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • +11 more
  • Zilovertamab vedotin
  • Duarte, California
  • +13 more
Jan 12, 2023

Waldenstrom Macroglobulinemia, DASATINIB Trial in Boston (Dasatinib)

Recruiting
  • Waldenstrom Macroglobulinemia
  • DASATINIB
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Mar 22, 2022

Waldenstrom Macroglobulinemia Trial in Boston (Loncastuximab Tesirine, Dexamethasone)

Recruiting
  • Waldenstrom Macroglobulinemia
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Mar 1, 2022

Oxford Pre-cancerous Lymphoproliferative Disorders Study

Recruiting
  • Pre-cancerous Lymphoproliferative Disorders
    • Oxford, United Kingdom
      Churchill Hospital, Oxford University Hospitals Trust
    Feb 19, 2020

    Lymphoma Trial in Worldwide (Zanubrutinib Oral Capsule)

    Not yet recruiting
    • Lymphoma
    • Zanubrutinib Oral Capsule
    • Leuven, Belgium
    • +8 more
    Sep 27, 2023

    Non-Hodgkin's Lymphoma (NHL), Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM) Trial

    Completed
    • Non-Hodgkin's Lymphoma (NHL)
    • +2 more
      • (no location specified)
      May 14, 2020

      Waldenström's Macroglobulinemia Trial in Ulm (Dexamethasone, Rituximab, Cyclophosphamide, Dexamethasone, Rituximab,

      Active, not recruiting
      • Waldenström's Macroglobulinemia
      • Dexamethasone, Rituximab, Cyclophosphamide
      • Dexamethasone, Rituximab, Cyclophosphamide, Bortezomib
      • Ulm, Germany
        University Hospital Ulm
      May 26, 2022

      Waldenström Macroglobulinemia (WM) Trial in Worldwide (Acalabrutinib (ACP-196))

      Active, not recruiting
      Has Results
      • Waldenström Macroglobulinemia (WM)
      • Acalabrutinib (ACP-196)
      • Santa Barbara, California
      • +37 more
      Mar 17, 2022

      Waldenström's Macroglobulinemia Trial in Worldwide (Ibrutinib, Placebo, Rituximab)

      Completed
      Has Results
      • Waldenström's Macroglobulinemia
      • Los Angeles, California
      • +47 more
      Feb 9, 2021

      Waldenstrom Macroglobulinemia Trial in Germany, Greece (Ibrutinib / Bortezomib / Rituximab)

      Active, not recruiting
      • Waldenstrom Macroglobulinemia
      • Ibrutinib / Bortezomib / Rituximab
      • Berlin, Germany
      • +14 more
      Mar 7, 2022

      Hematologic Cancer Trial in Israel, United States (ABBV-101)

      Not yet recruiting
      • Hematologic Cancer
      • Lone Tree, Colorado
      • +7 more
      Feb 22, 2023